Clinical Trials · NCT00981682
Long Term Safety Assessment of SER120 in Patients With Nocturia
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Serenity Pharmaceuticals, Inc.
- Enrollment
- 376
- Start date
- Aug 2009
- Locations
- 1 site, United States
- Primary endpoint
- Mean Serum Sodium